Bangual, Sapura J.
HRN: 08-57-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2024
CEFTAZIDIME 1GM (VIAL)
08/07/2024
08/14/2024
IV
1g
Q8
PTB Tx After Lost To Ff Up
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes